CB Machado

Universidade Federal do Ceará · CE · 16 publicações em 2022–2025

Acute Myeloid Leukemia ResearchAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchRetinoids in leukemia and cellular processes

Principais coautores no Nordeste tamanho = publicações em comum

IV Barreto BMD Nogueira FMCP Pessoa MEA Moraes MOM Filho RM Ribeiro RB Gadelha AKC Machado Caroline Aquino Moreira-Nunes DS Oliveira LS Cunha RC Montenegro

Publicações recentes

2025 3

SURVIVAL OUTCOMES AND PROGNOSTIC DETERMINANTS IN CHRONIC MYELOID LEUKAEMIA: ANALYSIS OF RISK SCORES, MOLECULAR RESPONSE, AND TREATMENT DYNAMICS
Medicina · Hematology Transfusion and Cell Therapy
CLINICAL AND THERAPEUTIC PROFILE OF A CHRONIC MYELOID LEUKAEMIA COHORT IN GENERAL HOSPITAL AT FORTALEZA
Medicina · Hematology Transfusion and Cell Therapy
PROGNOSTIC SCORES AND MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKAEMIA: COMPARATIVE ANALYSIS AND PREDICTIVE MODELLING IN A REAL-WORLD COHORT
Medicina · Hematology Transfusion and Cell Therapy

2024 7

IMPACT OF HIGH-RISK CYTOGENETICS ON THE SURVIVAL OF NON-APL ACUTE MYELOID LEUKEMIA PATIENTS
Medicina · Hematology Transfusion and Cell Therapy
AVALIAÇÃO IN SILICO DA EXPRESSÃO GÊNICA DAS ISOFORMAS DA TELOMERASE (HTERT) EM LEUCEMIA LINFOBLÁSTICA AGUDA.
Bioquímica, genética e biologia molecular · Hematology Transfusion and Cell Therapy
RISK FACTORS'IMPACT ON THE OVERALL SURVIVAL OF ACUTE LYMPHOBLASTIC LEUKEMIA ADULT PATIENTS IN FORTALEZA
Medicina · Hematology Transfusion and Cell Therapy
ANÁLISE POR DOCKING MOLECULAR DO POTENCIAL INIBITÓRIO DO GALATO DE EPIGALOCATEQUINA (EGCG) SOBRE A MUTAÇÃO JAK2-V617F EM LEUCEMIA MIELOIDE AGUDA
Farmacologia e toxicologia · Hematology Transfusion and Cell Therapy
AVALIAÇÃO IN SILICO DA EXPRESSÃO GÊNICA DO COMPONENTE DO CICLO CIRCADIANO EM LEUCEMIA MIELOIDE AGUDA
Neurociência · Hematology Transfusion and Cell Therapy
AVALIAÇÃO POR DOCKING MOLECULAR DO EFEITO POTENCIAL DO KAEMPFEROL (KPL) NA INIBIÇÃO DE JAK2-V617F EM PACIENTES COM LEUCEMIA MIELOIDE AGUDA
Medicina · Hematology Transfusion and Cell Therapy
PARP AND PARG INHIBITION SELECTIVELY IMPAIR METABOLISM OF B-ALL CELL LINES AND INDUCE CYTOTOXICITY THROUGH DISTINCT CELL-DEATH PATHWAYS
Medicina · Hematology Transfusion and Cell Therapy

2023 3

NESTED-PCR VS RT-QPCR: UMA COMPARAÇÃO DA SENSIBILIDADE NA DETECÇÃO DE ALTERAÇÕES GENÉTICAS EM PACIENTES COM LEUCEMIAS AGUDAS
Medicina · Hematology Transfusion and Cell Therapy
ASSOCIAÇÃO ENTRE PARÂMETROS IMUNOFENOTÍPICOS E ESTRATIFICAÇÃO DE RISCO DE PACIENTES PORTADORES DE LEUCEMIA MIELOIDE AGUDA
Medicina · Hematology Transfusion and Cell Therapy
PARP1 IS DIFFERENTIALLY EXPRESSED IN BCR-ABL P190+ ALL PATIENT SAMPLES AND TARGETING PARP INHIBITION INDUCES CELL DEATH COMPARABLE TO THAT OF TYROSINE-KINASE GOLDEN STANDARD IN PRE-CLINICAL MODELS
Medicina · Hematology Transfusion and Cell Therapy

2022 3

EPIDEMIOLOGICAL AND MOLECULAR PROFILE OF PATIENTS WITH ACUTE MIELOID LEUKEMIA IN CEARÁ
Medicina · Hematology Transfusion and Cell Therapy
PARP INHIBITION INDUCES PHILADEPHIA P190 POSITIVE ACUTE LYMPHOID LEUKEMIA CELL DEATH IN LEVELS SIMILAR TO IMATINIB TREATMENT
Medicina · Hematology Transfusion and Cell Therapy
EPIDEMIOLOGICAL AND MOLECULAR PROFILE OF ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN CEARÁ
Medicina · Hematology Transfusion and Cell Therapy

Contagens só com publicações em revistas com Qualis (filtro na tela inicial). Dados obtidos de fontes abertas: OpenAlex (CC0), ROR (CC0), CAPES Dados Abertos (CC-BY), INEP e IBGE. Encontrou um erro sobre você? Saiba mais. Criado por Gabriel Pina.